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6-mercaptopurine  (6-MP) ~ has  been  shown  to  suppress  the  expression  of 
certain  experimental  and  clinical  immune responses.  These include  delayed 
cutaneous  reactivity to  antigen  (1),  allograft rejection  (2),  manifestations  of 
certain "autoimmune"  disorders  (3),  and  some types of humoral antibody re- 
sponse  (4). The mechanisms involved in these suppressive effects of 6-MP  are 
still  open to question. Evidence has been presented both for specific immuno- 
suppressive (5)  and nonspecific anti-inflammatory (6)  actions. 
This  study describes in  vivo and  in  vitro functional  studies  in  guinea pigs 
receiving  6-MP  after  presentation  with  Mycobacterium  tuberculosis.  This 
model was chosen to study the effect of 6-MP upon developing cellular immunity 
after preimmunization, the situation most analogous to the conditions of clinical 
use.  Specific attention was paid to the two major cell  type populations known 
to be important in the manifestations of delayed hypersensitivity, the lympho- 
cytes and monocytes-macrophages (7).  Sequential  comparative measurements 
in vivo were made of: (a) patterns of skin test reactivity to tuberculin, irritants, 
and  certain vasoactive substances;  (b)  patterns  in levels of circulating leuko- 
cytes; (c) transfer studies involving specific subpopulations of cells;  (d)  several 
quantitative  in vitro measurements of lymphocyte and monocyte reactivities, 
such as:  (i) lymphocyte blast cell transformation and proliferation in response 
to tuberculin or phytohemagglutinin;  (ii) macrophage inhibition factor (MIF) 
activity production;  (iii) macrophage function. 
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AI-00309 and IROI-AI-10591,  American Cancer Society institutional grant IN-38-K, and the 
Friends of Judy Netzky Fund of Philadelphia. 
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1  Abbreviations used in this paper: CFA, complete Freund's adjuvant;  [3H]Tdr, tritiated 
thymidine; I.I.I., isotope incorporation index; MIF,  macrophage inhibition factor;  6-MP, 
6-mercaptopurine;  NHS,  normal human  serum; PBS, phosphate-buffered saline; PHA, 
phytohemagglutin;  PPD,  purified protein derivative;  SRS-A, slow-reacting substance  of 
anaphylaxis. 
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Materials  and Methods 
General Protocol.- 
Animals: Albino outbred guinea pigs, 600-850  g in weight, were obtained from the Stuttle 
Guinea Pig Farm Bristol, Pa., and the Harvard Animal Research Center, Cambridge, Mass. 
Induction  of sensitization:  All animals received on  day  0  a  total of  1.0  ml of  complete 
Freund's  adjuvant  (CFA),  containing  1.0  mg of  heat-killed mycobacteria  (H37Ra,  Difco 
Laboratories,  Detroit,  Mich.)  by  multiple  footpad  and  subcutaneous injections of  0.1  ml 
each. 
6-MP treatment:  The animals were  divided into two  groups.  Group A  (105  animals)  re- 
ceived 6-MP  (kindly supplied by Dr.  George Hitchings, Burroughs-Wellcome Co., Research 
Triangle Park, N. C.).  10 daily doses of 35-50 mg/kg were given on days 4-14 by deep intra- 
muscular injection.  Group B  (136 animals)  received equivalent volumes of  the phosphate- 
buffered NaOH diluent instead of the 6-MP on days 4-14. 
Skin  Tests.--Animals  were tested on the day before receiving CFA and at weekly inter- 
vals thereafter until termination of the study:  (a) Tuberculin skin test reactivity was meas- 
ured by the intradermal injection of 0/1 ml of PPD-S  (5 TU, kindly supplied by Dr. Lydia 
Edwards, Tuberculosis Section, National Communicable Disease Center, U.S. Public Health 
Service). In selected studies, PPD  (supplied by Mr. G. N. Freirichs, Ministry of Agriculture 
Fisheries and  Food,  Central Veterinary Labs,  Weybridge,  Surrey,  England)  was  also  used 
in various concentrations. Skin test reactions were read at 36 h and expressed as the mean of 
two perpendicular diameters of induration.  (b)  Skin reactivity to irritants was measured by 
the injection of 0.1 ml of turpentine-olive oil (1/4: vol/vol ratio); readings were made similar 
to that for the tuberculin skin test. (c) Skin reactivity to vasoactive substances was measured 
by the intradermal injection of (i) 0.02 ml of histamine, 1:10,000; (ii) compound 48-80 (3.5 
mg/ml,  kindly  supplied  by  Dr.  A.  Kligman,  Department  of  Dermatology,  University of 
Pennsylvania); (iil)  bradykinin (1,  10, and 50 #g, kindly supplied by Dr. J.  Spragg, Robert 
Breck Brigham Hospital, Boston, Mass.); and (iv) the slow-reacting substance of anaphylaxis 
(SRS-A, 1, 5, and 10 U, kindly provided by Dr. R. Orange, Robert Breck Brigham Hospital). 
Measurements of wheal responses to these substances were made 20 min after injection. (d) 
Responses  to  possible  chemical  mediators  of  delayed  hypersensitivity were  measured  by 
intradermal injection of 0.1  ml of material containing MIF activity. This lymphokine was 
produced by the incubation of 30 X  106 lymphocytes (obtained from lymph nodes of guinea 
pigs sensitized to tuberculoprotein, with 20 #g/ml of Weybridge PPD [8] in HEPES-buffered 
Roswell Park Memorial Institute Medium-1640 (Grand Island Biological Co., Grand Island, 
N.Y.). The culture supernatant was concentrated five times, dialyzed, and shown to contain 
MIF activity by its ability to reversibly inhibit active migration of normal guinea pig peri- 
toneal macrophages from capillary tubes in vitro. When injected intradermally,  this  super- 
natant caused a  monocyte infiltrate (9)  in the skin of normal, unsensitized animals. Indura- 
tion was measured at 16 h. 
Formed  Blood  Elements.--Sequential  measurements  were  made  weekly  of  hematocrit, 
total and differential leukocyte counts, and platelets. 
Cell Transfer  Studies.--In  these experiments, 1.0-3.0 X  l0 s cells from normal, unsensitized 
animals were obtained from (a) bone marrow, or (b) minced lymph nodes. The bone marrow 
cells were obtained from the femurs, tibia, and humeri by gentle flushing with RPMI-1640, 
through a  22-gauge needle. The cell suspension was transferred to  10-ml glass test tubes for 
settling of particulate material and suspended by passage through a 25-gauge needle. Mesen- 
teric, preaortic, axillary, and inguinal lymph nodes were excised,  minced, and passed through 
fine mesh onto a 5-cm column of glass beads (VirTis 16-220, VirTis Co., Inc., Gardiner, N.Y.) 
(10).  After an incubation period of 15 rain at 37°C, the nonadherent node cells,  consisting of 
over 97% small lymphocytes, were eluted from  the  column  at  a  flow  rate  of  1-2  ml/min. 
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group A who had received CFA on day 0, followed by daily injections of 6-MP on days 4-14, 
with cell transfer carried out on days 22-24;  (b) guinea pigs of group B, sensitized with CFA, 
followed by placebo; (c) normal, unsensitized guinea pigs. As a further control in the cell trans- 
fer experiments, selected members of each recipient group received Hanks' solution obtained 
from the cell washings instead of the bone marrow or lymph node cells from the donors. 
In  a  reverse type of cell  transfer experiment, guinea  pigs injected ~ith  CFA on  day 0, 
followed by 6-MP or placebo treatment on days 4-14, received intraperitoneal injections of 40 
cm a of light mineral oil (Marcol, or Bayol, Exxon Chemical Co., New York) on day 24-28.  3 
days later, bone marrow and peritoneal cells were collected from each animal, washed several 
times with chilled Hanks' solution, and injected intravenously in amounts of 1.0-3.0  X  l0 s 
cells into normal, unsensitized guinea pigs. 
All recipients were skin  tested with a  series of  several  doses  of  PPD  (Weybridge)  and 
turpentine-oil 36 h  before intravenous cell transfer.  18 h  after transfer, the PPD and irritant 
skin tests were repeated. 
Lympllocyte  C¢dture.  The proliferation of lymphocytes cultured either with phytohemag- 
glutinin (PHA) or tuberculin was studied as previously described by us in detail (11). Lympho- 
cytes were cultures for 3 days with PHA (PHA-P, Difco Laboratories, final concentration 1.25 
#g/ml) and 5 days with old tuberculin (OT-Jensen-Salsbery Laboratories, Kansas City, Mo. 
final concentration, 0.5 mg/ml) or control cultures, without any PHA or tuberculin. The  in- 
corporation  of  tritiated  thymidine  ([aH]Tdr,  6.7  Ci/mM,  New  England  Nuclear,  Boston, 
Mass.)  was measured by standard scintillation counting techniques and expressed as an iso- 
tope incorporation index (I.I.I.) : 
I.I.I.  = 
mean counts per minute in vials containing PHA or tuberculin 
mean counts per minute in vials containing only control medimn" 
In selected cultures, lymphocyte proliferation was also assayed by the percentage of cells 
incorporating isotope, indicated by autoradiographic techniques. The cell button in each such 
culture was washed twice, resuspended in normal human serum (NHS), and layered on gelatin- 
coated slides. These smears were dried, incubated with Kodak NTB-2  (Eastman Kodak Co., 
Rochester, N. g.) emulsion for 7 days, developed with Kodak developer (Dektal or D-19), and 
stained with Giemsa solution.  Cells were considered labeled if they contained at least three 
times the number of grains seen in the background. The incidence of mitotic division was also 
estimated in selected cell cultures using Colcemid, 20 #g/ml (12). The results were  expressed 
as mitotic figures seen per 1,000 lymphoid cells counted. 
M1F Acti~,ily Measurements. 
(a)  The direct measurement of inhibition by tuberculin of the in vitro migration of macro- 
phages obtained from animals in group A or B was carried out by the methods described by 
David (8). On day 21, animals were injected intraperitoneally with Marcol oil (Humble Oil  & 
Refining Co., Houston, Tex.); 72 h later, the peritoneal cavity was ]avaged with heparinized (1 
U/ml) chilled Hanks' solution. The peritoneal cells obtained were washed twice, drawn into glass 
napillary tubes, and ceutrifuged at 200 g for 5 rain. The glass capillary tubes were fractured at 
the cell-medium interface and placed in small lucite or Sykes-Moore chambers (Bellco Glass, 
Inc., Vineland, N.J.). The chambers were filled with minimal essential medium (Grand Island 
Biological  Co.)  or RPMI-1640  (Grand Island Biological Co.)  containing either 20%  NHS .2 
(as described above) or 15% normal guinea pig serum pIus 5% fetal calf serum. Various con- 
centrations of PPD were added to the test chambers. At 24 or 36 h. each chamber was visualized 
microscopically, and slide images were projected and traced on calibrated paper. The migration 
area was then cut out and weighed; the weight was used to represent the area of migration. The 
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results were expressed as the percentage of inhibition equal to: 
1.00 -- migration without antigen -- migration with antigen X  100. 
migration without antigen 
(b) The indirect measurement of migratory inhibition factor production was determined by 
a modification of the method of Rocklin et al. (13).  Lymph node cells obtained from unsensi~ 
tized animals and from selected animals in groups A and B were tested for their ability to pro- 
duce a soluble substance capable of reversibly inhibiting the migration of peritoneal exudate 
cells obtained from normal, unsensitized guinea pigs. Lymph node cell suspensions were trans- 
ferred in 10-ml volumes to test tubes containing cotton wool  (Fisher Scientific Type A, Fisher 
Scientific Co.,  Pittsburgh, Pa.)  and incubated at 37°C  for  15 min in a  5%  CO2,  10% 02 
atmosphere. The nonadherent cell population was removed, washed twice in medium, and sus- 
pended in replicate incubation mixtures containing final concentrations of 18 X  106 cells/3 ml 
and incubated in 5~o CO2,  10% 02. The supernatants of each incubation mixture were re- 
moved in 12 and 24 h, and concentrated to/a~ of the original volume by vacuum dialysis in 
previously boiled membranes (Arthur H. Thomas Co.,  Philadelphia, Pa.).  They  were  then 
dialyzed against fresh medium containing either 20% NHS* or a  mixture of guinea pig and 
fetal calf serum. The dialyzed supernatant was  then used to fill lucite chambers containing 
capillary tubes packed with peritoneal exudate cells obtained from normal, unsensitized guinea 
pigs by oil installation, as described above. The four types of incubation mixtures were com- 
pared:  (1)  node cells plus  PPD  (Weybridge)  20 #g/ml;  (ii)  node cells without PPD;  (iii) 
node-free medium plus PPD; (iv) cell-free medium alone. 
The areas of migration of guinea pig macrophages incubated with the supernatants from i, 
ii, iii, and iv were measured after 24 h, and the percentage of indirect inhibition caused by the 
production of MIF by lymph node cells was expressed by the formula: 
a  d  i-~x-x  100. 
c 
Macrophage  Function  Studies.--The  macrophages were  initially defined  morphologically 
according to  the  description  of  Cohn  (10).  These  amoeboid,  phagocytic  cells  contained a 
single ovoid or indented nucleus and abundant cytoplasm. They were strongly adherent to 
glass by multiple cytoplasmic processes. Over 90% of this cell type could be shown to actively 
phagocytize latex particles (1.947 #m, Coulter Electronics Inc., Hialeah, Fla.). The cytoplasm 
contained vacuoles, oil droplets, and a glistening internal structure. 
Phagocytosis:  15  X  106  peritoneal cells with  the  morphologic characteristics of  macro- 
phages were suspended in 5.0 ml of RPMI-1640 medium, containing 20% NHS.  They  were 
incubated for 3 h in the presence of 14C microcombusted particles (final concentration, 1/zCi/ 
ml, New England Nuclear Corp.), in 15-ml sealed Erlenmeyer flasks under 5% CO2,  10% 02 
at 37°C.  Cells adhering to the glass walls of the chamber were then washed five times with 
Hanks' solution, removed by freezing and thawing, and transferred to glass fiber/filter discs 
for drying, radioactivity being subsequently determined by standard scintillation spectrom- 
etry methods. The results are expressed as counts per minute of ingested radioactive carbon 
per  106 macrophages. Estimates of  the number of cells adherent to  the glass surface were 
made by direct counting with a calibrated eyepiece and determining the protein content of the 
freeze-thaw effluent. 
In additional experiments, macrophages were placed in 1.0 ml of medium in Leighton tubes 
containing flying cover slips.  One  drop  of standardized latex particles  (1.947  #m,  Coulter 
Electronics, Inc.) was added. Incubation of the medium was continued for 2 h at 37°C, under 
10% 02,5%  CO2. The cover slips were removed, washed twice in phosphate-buffered saline 
(PBS), fixed in 6% gluteraldehyde, and observed by phase contrast microscopy for phagocyto- 1498  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY  BY  6-MP 
sis of the latex particles. Parallel cultures incubated in the absence of latex particles were ob- 
served for morphologic alteration (11). 
Adtzerence: 15  X  106 peritoneal macrophages, defined by morphology and the ability to 
phagocytose latex particles, were suspended in NHS* and passed on to a 5-cm column of alco- 
hol, KOH-cleaned glass homogenizing beads (VirTis no. 16-220).  After incubation under 10% 
02,  5% C02 for 45 rain,  the columns were washed with 4  vol of 0.2%  EDTA in buffered 
saline free of calcium and magnesium (14). The degree of adherence was estimated by the cal- 
culation: 
number of macrophages added -- number of macrophages nonadherent 
X  100. 
number of macrophages added 
Migrallcn rate: Peritoneal exudate cells were suspended in acid-cleaned glass tubes of pre- 
cise internal diameter (160 nm, Drummond Scientific Co.,  Broomall, Pa.), sealed with Crito- 
seal (Arthur H. Thomas), and centrifuged at 200 g for 5 rain. The tubes were placed in lucite 
chambers containing RPMI-1640 in 20% NHS*, carefully held in the horizontal position, and 
observed under microscopy with a calibrated eyepiece for the rate of migration of the advanc- 
ing front of macrophages within the tube.  Movement was expressed in terms of millimeters 
per 24 h. 
Viability: Phase-contrast microscopy criteria (15)  and eosin exclusion were used. Evalua- 
tion was made of both (a) those cells adherent to and spreading on glass and capable of phagoo 
cytosing latex particles, and (b) nonadherent cells in the fluid phase. 
RESULTS 
Skin  Test Reactivily.-- 
(a)  Skin  test  reactivity  to  tuberculin  was  markedly  suppressed  by  6-MP 
administration  (Fig.  1).  Animals  in  group  B  had  positive  skin  tests  to  PPD 
starting as early as day 14, with almost all animals reactive by day 21. In con- 
trast,  animals in group A  showed little skin test reactivity to PPD  for up to 6 
wk after discontinuation of 6-MP  therapy. 
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FIG. 1.  Effect of 6-MP administration on the development of delayed hypersensitivity to 
tubereuloprotein. Prolonged suppression of skin test reactivity to 5 TU PPD  was found in 
group A (•)  animals, often lasting several weeks after the cessation of 6-MP administration. S.  MICFL~.EL  PHILLIPS  AND  BURTON  ZWEIMAN  1499 
(b) To test for the nonspecific suppression of skin test reactivity by 6-MP, a 
variety of additional agents were used (Table I): 
Irritant skin tests: Group B animals showed marked erythema and induration 
36 h after intradermal injection of turpentine-oil. This response was significantly 
less (P <  0.05) in group A animals, although the differences were not as marked 
as seen in tuberculin skin test responses. Comparative measurements were nlade 
by a disc micrometer of the anterior-posterior diameters of the posterior foot- 
pads of groups A and B animals 21 days after CFA had been injected into these 
sites. The average diameter for the group A  animals was approximately 40% 
of that seen in group B, which suggested a depressed, nonspecific, inflammatory 
response to the injected CFA. 
TABLE I 
Elect of 6-MP on Skin Test Reactivity 
Mean diameter of induration on day 
1  7  14  21  28  35 
mm 
Turpentine:oil  19/18  16/19  13/20  15/21  16/20  20/21 
Histamine  16/14  15/17  16/18  17/16  18/17  16/15 
48-80  13/13  14/13  15/14  8/7  14/15  16/14 
SRS-A  15/12  14/13  13/16  11/14  13/12  NDJ; 
Bradykinin  9/8  10/8  11/14  10/9  ND  ND 
Lymphokine§  10/11  8/12  2/10  4/12  6/14  8/17 
PPD  2/2  2/2  2/5  2/7  3/9  5/11 
* Group A animals/group B animals (groups of at least six animals). 
:~ Not done. 
§ Lymphokine produced by lymphocyte interaction with antigen and known to contain 
macrophage inhibition factor activity. 
Vasoaetive  mediator  skin  tests:  Histamine,  compound  48-80,  SRS-A,  and 
bradykinin: No differences were noted between group A and group B  animals 
in the wheal responses seen 20 rain after intradermal injection of these agents. 
The  lymphokine  skin  test: Lymphokine from lymphocyte cultures  failed  to 
induce significant responses in the skin of group A animals during the period in 
which  PPD  skin test reactivity was markedly suppressed.  No suppression in 
response was seen in group B animals when compared with normal, unsensitized 
animals. However, with the development of systemic sensitivity to tuberculo- 
protein, the reaction to lymphokine increased, perhaps reflecting a response to 
the tuberculin contained in it. 
Blood Cellular Elements.--There was a rapid and marked decrease in the level 
of circulating inonocytes in group A  animals when compared with the level of 
those cells in animals of group B  (Fig. 2). A similar pattern of suppression was 
noted in the levels of hemoglobin, granulocytes and platelets. The level of large 1500  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY  BY  6-~P 
lymphocytes  (diameter  greater  than  10/~m)  was  moderately  suppressed  in 
group A animals. The suppression was most apparent on day 14,  and was fol- 
lowed  by mild  rebound  elevation  by day 28.  In contrast,  the  level  of small 
lymphocytes  (6-8/~m  diameter  with  characteristic  morphology)  was  only 
moderately suppressed  in  group A  (Fig.  3).  Conversely, monocytes, granulo- 
cytes, platelets,  and lymphocytes increased slightly in group B animals. 
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FIG. 2.  Effect of 6-MP administration on the circulating monocyte level. A rapid and 
dramatic suppression of total monocyte  count was found in group A (O  animals. 
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FIG. 3.  Effect of 6-MP administration on the circulating small lymphocyte level.  Signifi- 
cant although less striking suppression of total small lymphocyte count was found in group 
A  (e)  animals. 
Cell Transfer Studies.- 
Transfer of normal cells to group A  animals:  Selected animals of group A were 
utilized  as  recipients  in  cell  transfer  studies.  Tuberculin  skin  tests  were  per- 
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than 2-mm diameter induration. Recipient animals were injected intravenously 
with either:  (a)  1.5-2.0 X  10  s bone marrow cells,  (b)  1.5-2.0  X  108 glass non- 
adherent  lymph node cells,  or  (c)  Hanks' solution,  used as a  control. Normal, 
unsensitized  guinea pigs served as donors for the pooled marrow or node cells. 
Tuberculin skin tests were then repeated in recipients 18 h after transfer (Table 
II). 
Group A  animals receiving bone marrow cells showed a significantly greater 
subsequent  skin  test  response  to  tuberculin  compared  with  pretransfer  re- 
sponses. Animals receiving equivalent numbers of bone marrow cells, which had 
been  previously  passed  over  glass  bead  columns  to  remove  adherent  cells, 
showed a lesser increase in tuberculin skin test reactivity. Group A recipients of 
TABLE II 
Effect of Normal Cell Transfer into 6-MP-Treated Guinea Pigs on Day 21 
after CFA Administration 
Animals  Mean number and  Skin test* 
Cell source  per  range of transferred 
group  cells  Before  After 
X  10  7  mm 
Control: Hanks'  6  0  <2  <2 
solution 
Nonadherent  lymph  6  7.5  < 2  < 2 
node cells  (5-10) 
Bone marrow cells  9  7.5  <2  9.7  -4- 2.6 
(5-10) 
Nonadherent  bone  4  7.5  <2  3.4  4-  1.7 
marrow cells  (5-10) 
* Skin test  reactivity  (mean diameter of induration)  to 1 ug of PPD (Weybridge) injected 
before and 18 h after cell transfer. 
node cells showed no significant change in skin test responses. In limited experi- 
ments,  responses of group A  animals to intradermal  injection of turpentine-oil 
irritant  were  compared  before  and  after  receipt  of  the  normal  cells.  These 
responses changed in parallel with that to tuberculin, although to a lesser extent. 
As  a  control,  group  B  or  normal,  unsensitized  recipients  were  infused  with 
Hanks' solution, bone marrow, or lymph node cells in a manner similar to that 
described  above.  No significant change in  reactivity  to tuberculin  or irritant 
was noted. 
Transfer  of sensitized  animal  cells  to  normal  recipients:  Peritoneal  exudate 
cells were obtained on days 22-24 from group A  animals  or group B  animals. 
These  cells were washed, pooled within a group, and injected  intravenously in 
amounts of 1.5  )<  108 into normal, unsensitized  guinea pigs  (Table III). Skin 
testing 18 h  later demonstrated that in 7 of 11 cases peritoneal cell populations 
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lack of skin test reactivity in the group A donors. However, it should be noted 
that the number of peritoneal exudate cells utilized in these transfers was not 
adjusted for the fact that the exudate subpopulations of cells were different in 
group A and group B animals. 
These in vivo studies suggested that a primary site of action of 6-MP in sup- 
pressing delayed hypersensitivity was on the monocyte-macrophage population; 
its effects on the lymphoid cells were much less. Therefore, it was important to 
explore  the  functional  activity of  the  lymphocytes with  in  vitro  techniques 
allowing for more quantitative measurements. 
In  Vitro  Lymphocyte  _Proliferative Responses.--Fig.  4  shows  the  tuberculin- 
induced proliferative response, expressed as an isotope incorporation index of 
TABLE  III 
Effect of Transfer  of Cells from Sensitized Animals to Normal Recipients 
Cell source 
Recipient skin test reactivity* 
Before  24 h after 
Donor skin test 
reactivity* 
Peritoneal exudate cells  from A  <2 
donors (N  =  11) 
Peritoneal exudate cells  from B  <2 
donors (N  =  11) 
6.9  4-  2.7  2 
9.3  4-  3.1  7.5  ~  1.9 
* Skin test reactivity (mean diameter of induration) to 1/zg of PPD  (Weybridge) injected 
before and 24 h  after transfer of 1.5  X  l0  s peritoneal exudate cells. 
:~ Skirl  test reactivity of peritoneal exudate celI donor. 
<3  6-MP  ; 
4O- 
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%~ 
0  7  14  21  28  35 
DAYS  AFTER  SENS/T/ZAT/ON 
FIO. 4.  Effect  of  in  vivo  6-MP  administration  upon  in  vitro  proliferative  response  to 
PPD. Lymphocytes from guinea pigs, sensitized to CFA and  treated with 6-MP or placebo, 
were tested at weekly intervals for their response in vitro  to Koch's OT. No difference was 
observed between the two groups. The results are expressed as an I.I.I., as described under 
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lymphocytes  obtained  weekly  from  animals  of  groups  A  and  B  after  the 
injection of CFA.  It can  be  seen  that  there were  no  differences in  the mean 
responses, even though the lymphocytes were obtained during periods of marked 
suppression of tuberculin  skin reactivity in  animals of group A.  In  addition, 
no difference in the mean response to phytohemagglutinin was noted between 
the two groups. This similarity in proliferative responses, measured by scintil- 
lation spectrometry, was confirmed by autoradiographic studies of isotope in- 
corporation into  DNA  and  the  estimation  of  the  prevalence  of lymphocytes 
undergoing blastoid transformation and cell division (Table IV). 
TABLE IV 
Effect of 6-MP Administered  In Vivo on In Vitro Proliferati~'e Response to 
PtIA and OT 
Group*  In vitro mitogen  I.I.I.  Labeled~  Blast§  Mitotic index[] 
%  % 
A  None  -  1.1  9  1.3 
PHA  51  27  82  34 
OT  17  13  44  24 
B  None  -  0.6  11  0.4 
PHA  47  23  86  32 
OT  21  11  49  27 
Uns.  None  -  1.3  5  0.8 
PHA  59  32  92  38 
OT  1.2  1.6  7  1.0 
* A: cells derived from animals sensitized to CFA and treated with 6-MP; B: cells derived 
from animals sensitized to CFA and treated with NaOH diluent; Uns. : cells derived from nor- 
mal, unsensitized  guinea pigs. 
Percent of cells labeled with [3H]Tdr by autoradiography. 
§ Percent of cells undergoing morphologic blast cell transformation. 
I[ Number of cells in metaphase/1,000 cells counted. 
Production of Migration Inhibition Factor.--The effect of tuberculin in the in 
vitro migration of macrophages obtained from animals in groups A  and B  was 
first  studied  by  the  direct inhibition  technique.  Peritoneal  exudate  cells ob- 
tained  from  animals  in  groups  A  and  B  were  assayed for  migratory  rate  in 
individual chambers with and without the presence of tuberculin. There was no 
significant difference in the percentage of animals in each group whose peritoneal 
cells were  markedly inhibited  in  this  activity by  the  presence  of  tuberculin 
(Table V). In addition, the mean degree of inhibition produced by tuberculin 
was similar for the cells obtained from both groups. 
However,  it was  observed that  the  mean  migratory  rate  of  the peritoneal 
exudate  cells from  group  A  animals  in  control chambers  containing medium 
without tuberculin was significantly less than that of cells obtained from group 
B  animals in the same medium. These peritoneal cells have been shown  (16) to 1504  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY  BY  6-MP 
be a heterogeneous group consisting mainly of macrophages, with a minority of 
lymphocytes of various sizes and small numbers of cells of other types. There- 
fore, the question arose as to whether the decreased migration rate was due to 
lymphocyte action or intrinsic macrophage limitations. 
The first possible explanation was that the lynlphocytes present in the peri- 
toneal cell collection obtained  from  group A  animals spontaneously liberated 
excess MIF  activity or some cytotoxic factor. 
TABLE  V 
Macrophage Inhibition Factor Activity 
Direct Assay 
Group*  Tested  PositiveS:  Inhibition 
A  25  21 
B  26  23 
Indirect Assay 
Group§  Tested  Positive L 
% 
84  ::k  12 
87d=9 
Inhibition'-  Inhibition** 
%  % 
A  12  10  80  4-  13  19  :t=  13 
B  11  9  83  =k  11  13  :t=  12 
* A: peritoneal exudate cells from animals injected with CFA and treated with 6-MP; B: 
peritoneal exudate cells from animals injected with CFA and  treated with NaOH control 
solution. 
2~ Positive defined as PPD-induced inhibition of migration = 30~y~ as compared with migra- 
tion in Ag-free medium. 
§ A: MIF produced by lymphoeytes of group A animals; B: MIF produced by lympho- 
cytes of group B animals. 
1[ Defined as inhibition of migration _-->30% (see text). 
¶ Percentage inhibition of normal guinea pig exudate cells in the presence of MIF. 
** Percentage inhibition of normal guinea pig exudate cells after MIF had been  removed 
and replaced with fresh medium. 
Therefore,  the  initial  investigations  centered  on  a  comparison  of  the  ap- 
pearance of MIF  activity in  the supernatants  of lymphocyte cultures derived 
from animals from groups A  and B  in the presence and absence of tuberculin. 
The patterns of macrophage migration inhibitory activity in  the supernatants 
were similar when the lymphocytes from groups A  and B  were incubated with 
tuberculin  (Table V). The migration rate of such peritoneal cells from unsen- 
sitized animals was  then  compared after the  supernatant  had  been  removed. 
The cells regained normal migratory capacity. Therefore, one could not explain 
the depressed migratory rate of peritoneal cells obtained from group A  animals 
on the basis of the elaboration of a  cvtotoxic substance. In some experiments, S.  MICHAEL  PHILLIPS  AND  BURTON  ZWEIMAN  1505 
serial  dilutions were made of the supernatants obtained when lymphocytes from 
animals of groups A and B were incubated with tuberculin. In this way it was 
found that approximately equal amounts of MIF were  elaborated  by compa- 
rable numbers of lymphocytes from each group. There was no significant MIF 
activity in  the supernatants  when lymphocytes from either group were incu- 
bated in the absence of tuberculin. Therefore, the decreased spontaneous migra- 
tory rate  of peritoneal  exudate  cells  from group A  animals  could not be  ex- 
plained on the basis of spontaneous elaboration of MIF or cytotoxic activity 
by lymphocytes within that exudate population. 
Macrophage-Monocyle Function.--Another  possibility was that there was an 
alteration  in  the intrinsic  macrophage function in  the  6-MP-treated  animals. 
Therefore, the activities of the peritoneal cells from groups A and B were studied 
TABLE  VI 
Peritoneal Macrophage Studies 
Group  Total macrophage* yield  Migratory rate  Phagocytosis~  Adherence§  Viabilityll 
N  10  6  mm/h  cpm X  10  5  % 
A  16.91 4-  6.81  0.42  4- 0.24  1.2  4-  0.7  61  4-  14  97 
B  83.3 4-  16.3  0.94  4- 0.29  3.7  4-  1.6  88  4-  8  98 
* Defined by morphologic and phagocytic criteria. 
.~ Defined as cpm of 14C particles ingested per 10  5 macrophages. 
number of macrophages added -- number not adhering glass 
§ Defined as 
number macrophages added 
II Defined by trypan blue exclusion and phase contrast criteria. 
X 100. 
in a number of ways: a  significantly lower number of morphologically defined 
macrophages could be obtained by lavage of the peritoneal cavities in group A 
compared with group B animals (Table VI) 72 h after intraperitoneal instillation 
of mineral  oil.  There was also a  mean decrease of 57 %  in  the number of re- 
covered lymphocytes. Once  obtained,  the  cells  of  group  A  animals  were  as 
viable as those of group B, but were noted to spread less well on glass and to 
have  a  less  highly developed  refractile  internal  structure.  In  addition,  these 
cells showed significant impairment in several in vitro functions when compared 
with  cells  siilarly  obtained  from  group  B  animals.  These  included  (a)  ad- 
herence to glass beads,  (b) migration on glass surfaces, and (c) phagocytosis of 
14C-labeled particles.  Phagocytosis was also measured by visual determination 
of the number of ingested latex particles per macrophage. Mean and standard 
deviation values were obtained in these studies  (Fig.  5).  They suggested that 
the suppressed phagocytic activity of cells from group A animals was a general 
phenomenon involving most, if not all,  of the cells. 1506  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY  BY  6-MP 
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FIG.  5.  Effect on in vivo administration of 6-MP upon subsequent phagocytosis by peri- 
toneal macrophages in vitro. A  general  decrease involving most, if  not  all,  cells  was  found 
with cells from 6-MP-treated animals. 
DISCUSSION 
The results of this study confirm previous findings (1) of the capacity of 6- 
MP to suppress the appearance of tuberculin skin test reactivity in the guinea 
pig. Current evidence from a number of studies suggests that the expression of 
the  delayed  hypersensitivity  response  requires  at  least  two  populations  of 
mononuclear inflammatory cells. One cell type is a lymphocyte that has become 
specifically sensitized to the antigen in question. Such cells probably represent 
a small minority of the inflammatory cells at the skin test site (17). The majority 
of cells appear to be young, rapidly dividing, monocytic cells of bone marrow 
origin (18) that are recruited secondarily at the site of the interaction of antigen 
with sensitized lymphocytes by release of biologically active lymphokines (19). 
These studies are designed Io study the specific and nonspecific cell populations 
during 6-MP-induced suppression of delayed hypersensitivity. 
The results suggest  that a  major mechanism of 6-MP-induced suppression 
during developing delayed hypersensitivity is related to the drug's action on the 
"nonsensitized" cells of bone marrow origin. The following observations provide 
evidence for this conclusion: (a) The depression of blood monocyte levels was 
relatively greater than  that  seen in  levels of small  and  medium lymphocytes 
during 6-MP  treatment.  (b)  Sequential studies  showed a  striking suppressive 
effect of 6-MP on the marrow at a  time when blood monocyte levels were  de- 
pressed.  (c)  Animals  with  depressed  tuberculin  skin  reactivity  after  6-MP 
treatment exhibited suppressed skin reactivity to injected lymphokines. These S.  MICHAEL  PHILLIPS  AND  BURTON  ZWEIMAN  1507 
functionally defined substances are liberated from sensitized lymphocytes after 
in vitro interaction with a  specific antigen  (7). Intradermal injection of these 
supernatants has been reported (9) to induce a delayed hypersensitivity response 
characterized by infiltration of mononuclear cells.  (d) Transfer of bone marrow 
cells from normal, unsensitized donors to animals in which tuberculin skin test 
reactivity had been suppressed after CFA and 6-MP treatment was followed 
by positive skin test responsiveness within 24 h.  (e) In vitro measurements of 
macrophage  function  demonstrated  decreased  adherence  to  glass,  migratory 
rate, and phagocytic capacity in the cells of the group A animals. Studies of the 
in vivo kinetics of this cell population will be reported later. 
The data from this study also suggest that 6-MP, as utilized here, does not 
exert a  striking effect on the development of a  lymphoid cell population that 
becomes sensitized to tuberculin. (a) There was only a very modest suppression 
of the level of circulating small lymphocytes compared with the observed effects 
on monocyte levels. This difference in drug effect on the  two cell types was 
reflected in a relative increase in the percentage of lymphocytes in the mineral- 
oil-induced peritoneal exudates obtained from 6-MP-treated animals compared 
with  exudates  from untreated  animals.  In addition,  there  was no significant 
effect on the morphology of the lymph nodes, in contrast to the marked deple- 
tion of the monocyte population in the bone marrow.  (b) In at least some in- 
stances, peritoneal exudate cells from 6-MP-treated  animals with suppressed 
tuberculin delayed hypersensitivity could transfer such reactivity to normal, 
unsensitized recipients.  (c)  As noted above, bone marrow  cells from normal, 
unsensitized donors could reconstitute delayed hypersensitivity in  animals in 
which this was suppressed by 6-MP treatment.  Since expression of such skin 
test reactivity probably requires the presence of a small population of lymphoid 
cells sensitized to the antigen, one may assume that such cells were present in 
the 6-MP-treated animals, even though skin test reactivity was markedly sup- 
pressed. (d) Lymphoid cells from 6-MP-treated animals incubated with antigen 
in vitro reacted in  a  manner similar  to  that of cells from animals  given the 
placebo solution. There was a  similar sequential development of proliferative 
responsiveness of lymphocytes to tuberculin. This pattern had previously been 
observed in our laboratory (20)  when lymphocytes of animals receiving CFA 
without any additional therapy were used, and is thought, as reviewed by Ling 
(21), to indicate development of cells immunologically committed to tuberculin. 
In  addition, lymphocyte responses to a  nonspecific mitogen, phytohemagglu- 
tinin, were not affected. This finding was evidence against nonspecific in vivo 
impairment of lymphocyte reactivity. (e) In vitro incubation with tuberculin 
led to a similar release of migration inhibition factor by lymphocytes obtained 
from  both  6-MP-treated  and  placebo-treated  animals  on  days  21-24  when 
tuberculin  skin  test  reactivity  was  markedly  suppressed  in  those  animals 
previously treated with 6-MP. As 6-MP treatment had been discontinued for 
1 wk, all the 6-MP should have been metabolized in vivo (22). There was no evi- 1,~08  SUPPRESSION  OF  DELAYED  HYPERSENSITIVITY  BY  6-YlP 
dence of nonspecific release of MIF or of cytotoxic factors by these cells. At this 
time the presence of tuberculin led to similar degrees of inhibition in the migra- 
tion of peritoneal cells from both groups of animals in the direct MIF activity 
assay. 
The findings of this study can be considered in relationship to previous in- 
vestigations of the mechanisms of 6-MP action. The anti-inflammatory effect 
observed here was similar to that noted by Page et al.  (6)  and Hurd and Ziff 
(23) when irritant suspensions were used. The pattern of suppression of delayed 
hypersensitivity in the present study was also similar to that noted by Hoyer 
et al.  (1). 
A major effect of 6-MP is to reduce the number of mature monocytes that are 
able to participate actively in skin inflammatory reactions. This effect can be 
very prominent in the face of the known short half-life of such cells (24) and the 
findings by McCluskey et al. (17) that most cells in the delayed hypersensitivity 
skin test reaction are rapidly dividing ones. Hurd and Ziff (23)  observed that 
the depressive effect of 6-MP on cellular nonspecific inflammation correlated 
best with the decrease in circulating monocytes and the depression of rapidly 
dividing mononuclear cells in the dermal inflammatory response. Delayed skin 
test  reactivity is  suppressed  for only 1-4 wk  after discontinuation  of 6-MP 
treatment. In addition, 6-MP given for a period of time before, but not after, 
the sensitization injections does not lead to subsequent suppression of skin test 
reactivity (25).  The early stages of the immunologic response in experimental 
allergic thyroiditis are less  sensitive to 6-MP treatment that the later stages, 
after the onset of clinical disease  (26).  This mechanism  of drug  action may 
explain  the  clinical  observation  that  6-MP-induced  immunosuppression  is 
dependent on continuous drug administration. 
However, other studies have indicated that the effects of 6-MP on cellular 
immunity depend on the timing of 6-MP administration relative to antigenic 
stimulation.  Recent  evidence  (27)  has  suggested  that  the  critical  period  of 
antigen recognition may occur within 48 h after primary exposure of the subject 
to that antigen. Borel and Schwartz (25) found that immunologic nonreactivity 
to a specific antigen could be induced in rabbits by 6-MP administration. They 
concluded  that,  under certain  experimental conditions,  the  inhibition  of ex- 
pression of delayed hypersensitivity in drug-treated animals was accompanied 
by the inhibition of development of sensitized lymphoid cells to  the  specific 
antigen as well as by an anti-inflammatory effect. 
Although the evidence in the present study did not suggest any significant 
effect on  the  development  of  tuberculin-sensitized  lymphocytes,  it  may  be 
questioned whether the administration of the drug sooner after the injection of 
CFA may have been associated with such a suppressive effect. The protocol of 
the present study was specifically designed to assay the effects of 6-MP started 
at a later time. Studies of alternative modes of drug administration are now in S.  MICHAEL  PHILLIPS  AND  BURTON  ZWEIMAN  i509 
progress in this laboratory, in an attempt to define further the mechanisms of 
6-MP activity. 
SUMMARY 
The mechanism of suppression of delayed hypersensitivity to tuberculopro- 
rein by 6-mercaptopurine (6-MP)  was studied  in guinea pigs. Under the con- 
ditions  of the protocol, suppression of tuberculin delayed skin  test reactivity 
was not associated with a significantly altered end-organ response to mediators 
of  permeability.  No  significant  alteration  of  in  vivo  lymphoid  activity,  as 
measured  by  reconstitution  studies,  was  found.  In  addition,  lymphoid  cells 
from 6-MP-treated  animals reacted  in  a  fashion  similar to  those of placebo- 
treated animals with respect to (a) antigen-induced lymphocyte proliferation, 
(b)  antigen-induced  liberation  of  macrophage  inhibitor},  factor  activity,  (c) 
direct inhibition by antigen of peritoneal exudate cell migration. 
Conversely, suppression was seen in levels of blood monocytes and in vitro 
function  of macrophages from 6-MP-treated  animals  in  several  respects:  (a) 
adherence  to glass,  (b)  migratory rate,  (c)  phagocytic capacity. Therefore, it 
would appear that a major mechanism of 6-MP-induced suppression of delayed 
hypersensitivity is through its action on effector cells. 
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